Skip to content

Clinical trials

Phase 2 Glycogen Storage Disease Type II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glycogen Storage Disease Type II Phase: Phase 2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20051
20081
20112
20121
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Withdrawn2
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company4
Amicus Therapeutics2
Shionogi2
BioMarin Pharmaceutical1
Columbia University1
Duke University1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glycogen Storage Disease Type II12
Glycogen Storage Disease2
Rare Diseases2
Lysosomal Storage Diseases1
Malnutrition1
Muscular Atrophy1
Obesity1
Weight Loss1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.